2022-04-012023-03-312023-03-31false13655344THORPE HEALTHCARE LTD2023-10-1647730iso4217:GBPxbrli:pure136553442022-04-01136553442023-03-31136553442022-04-012023-03-31136553442021-10-01136553442022-03-31136553442021-10-012022-03-3113655344bus:SmallEntities2022-04-012023-03-3113655344bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3113655344bus:FullAccounts2022-04-012023-03-3113655344bus:PrivateLimitedCompanyLtd2022-04-012023-03-3113655344core:WithinOneYear2023-03-3113655344core:AfterOneYear2023-03-3113655344core:WithinOneYear2022-03-3113655344core:AfterOneYear2022-03-3113655344core:ShareCapital2023-03-3113655344core:SharePremium2023-03-3113655344core:RevaluationReserve2023-03-3113655344core:OtherReservesSubtotal2023-03-3113655344core:RetainedEarningsAccumulatedLosses2023-03-3113655344core:ShareCapital2022-03-3113655344core:SharePremium2022-03-3113655344core:RevaluationReserve2022-03-3113655344core:OtherReservesSubtotal2022-03-3113655344core:RetainedEarningsAccumulatedLosses2022-03-3113655344core:LandBuildings2023-03-3113655344core:PlantMachinery2023-03-3113655344core:Vehicles2023-03-3113655344core:FurnitureFittings2023-03-3113655344core:OfficeEquipment2023-03-3113655344core:NetGoodwill2023-03-3113655344core:IntangibleAssetsOtherThanGoodwill2023-03-3113655344core:ListedExchangeTraded2023-03-3113655344core:UnlistedNon-exchangeTraded2023-03-3113655344core:LandBuildings2022-03-3113655344core:PlantMachinery2022-03-3113655344core:Vehicles2022-03-3113655344core:FurnitureFittings2022-03-3113655344core:OfficeEquipment2022-03-3113655344core:NetGoodwill2022-03-3113655344core:IntangibleAssetsOtherThanGoodwill2022-03-3113655344core:ListedExchangeTraded2022-03-3113655344core:UnlistedNon-exchangeTraded2022-03-3113655344core:LandBuildings2022-04-012023-03-3113655344core:PlantMachinery2022-04-012023-03-3113655344core:Vehicles2022-04-012023-03-3113655344core:FurnitureFittings2022-04-012023-03-3113655344core:OfficeEquipment2022-04-012023-03-3113655344core:NetGoodwill2022-04-012023-03-3113655344core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113655344core:ListedExchangeTraded2022-04-012023-03-3113655344core:UnlistedNon-exchangeTraded2022-04-012023-03-3113655344core:MoreThanFiveYears2022-04-012023-03-3113655344core:Non-currentFinancialInstruments2023-03-3113655344core:Non-currentFinancialInstruments2022-03-3113655344dpl:CostSales2022-04-012023-03-3113655344dpl:DistributionCosts2022-04-012023-03-3113655344dpl:AdministrativeExpenses2022-04-012023-03-3113655344core:LandBuildings2022-04-012023-03-3113655344core:PlantMachinery2022-04-012023-03-3113655344core:Vehicles2022-04-012023-03-3113655344core:FurnitureFittings2022-04-012023-03-3113655344core:OfficeEquipment2022-04-012023-03-3113655344core:NetGoodwill2022-04-012023-03-3113655344core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113655344dpl:GroupUndertakings2022-04-012023-03-3113655344dpl:ParticipatingInterests2022-04-012023-03-3113655344dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3113655344core:ListedExchangeTraded2022-04-012023-03-3113655344dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3113655344core:UnlistedNon-exchangeTraded2022-04-012023-03-3113655344dpl:CostSales2021-10-012022-03-3113655344dpl:DistributionCosts2021-10-012022-03-3113655344dpl:AdministrativeExpenses2021-10-012022-03-3113655344core:LandBuildings2021-10-012022-03-3113655344core:PlantMachinery2021-10-012022-03-3113655344core:Vehicles2021-10-012022-03-3113655344core:FurnitureFittings2021-10-012022-03-3113655344core:OfficeEquipment2021-10-012022-03-3113655344core:NetGoodwill2021-10-012022-03-3113655344core:IntangibleAssetsOtherThanGoodwill2021-10-012022-03-3113655344dpl:GroupUndertakings2021-10-012022-03-3113655344dpl:ParticipatingInterests2021-10-012022-03-3113655344dpl:GroupUndertakingscore:ListedExchangeTraded2021-10-012022-03-3113655344core:ListedExchangeTraded2021-10-012022-03-3113655344dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-10-012022-03-3113655344core:UnlistedNon-exchangeTraded2021-10-012022-03-3113655344core:NetGoodwill2023-03-3113655344core:IntangibleAssetsOtherThanGoodwill2023-03-3113655344core:LandBuildings2023-03-3113655344core:PlantMachinery2023-03-3113655344core:Vehicles2023-03-3113655344core:FurnitureFittings2023-03-3113655344core:OfficeEquipment2023-03-3113655344core:AfterOneYear2023-03-3113655344core:WithinOneYear2023-03-3113655344core:ListedExchangeTraded2023-03-3113655344core:UnlistedNon-exchangeTraded2023-03-3113655344core:ShareCapital2023-03-3113655344core:SharePremium2023-03-3113655344core:RevaluationReserve2023-03-3113655344core:OtherReservesSubtotal2023-03-3113655344core:RetainedEarningsAccumulatedLosses2023-03-3113655344core:NetGoodwill2022-03-3113655344core:IntangibleAssetsOtherThanGoodwill2022-03-3113655344core:LandBuildings2022-03-3113655344core:PlantMachinery2022-03-3113655344core:Vehicles2022-03-3113655344core:FurnitureFittings2022-03-3113655344core:OfficeEquipment2022-03-3113655344core:AfterOneYear2022-03-3113655344core:WithinOneYear2022-03-3113655344core:ListedExchangeTraded2022-03-3113655344core:UnlistedNon-exchangeTraded2022-03-3113655344core:ShareCapital2022-03-3113655344core:SharePremium2022-03-3113655344core:RevaluationReserve2022-03-3113655344core:OtherReservesSubtotal2022-03-3113655344core:RetainedEarningsAccumulatedLosses2022-03-3113655344core:NetGoodwill2021-10-0113655344core:IntangibleAssetsOtherThanGoodwill2021-10-0113655344core:LandBuildings2021-10-0113655344core:PlantMachinery2021-10-0113655344core:Vehicles2021-10-0113655344core:FurnitureFittings2021-10-0113655344core:OfficeEquipment2021-10-0113655344core:AfterOneYear2021-10-0113655344core:WithinOneYear2021-10-0113655344core:ListedExchangeTraded2021-10-0113655344core:UnlistedNon-exchangeTraded2021-10-0113655344core:ShareCapital2021-10-0113655344core:SharePremium2021-10-0113655344core:RevaluationReserve2021-10-0113655344core:OtherReservesSubtotal2021-10-0113655344core:RetainedEarningsAccumulatedLosses2021-10-0113655344core:AfterOneYear2022-04-012023-03-3113655344core:WithinOneYear2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113655344core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3113655344core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3113655344core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3113655344core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3113655344core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3113655344core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3113655344core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3113655344core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3113655344core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3113655344core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3113655344core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3113655344bus:Director12022-04-012023-03-3113655344bus:Director22022-04-012023-03-31

THORPE HEALTHCARE LTD

Registered Number
13655344
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

THORPE HEALTHCARE LTD
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

SINGH, Fiona Margaret
SINGH, Sarvjit

Registered Address

2 Maids Head Parade High Street
Thorpe-Le-Soken
Clacton-On-Sea
CO16 0DY

Registered Number

13655344 (England and Wales)
THORPE HEALTHCARE LTD
Balance Sheet as at
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets5312,810-
Tangible assets630,216-
343,026-
Current assets
Stocks733,564-
Debtors872,327100
Cash at bank and on hand16,771-
122,662100
Creditors amounts falling due within one year9(270,091)-
Net current assets (liabilities)(147,429)100
Total assets less current liabilities195,597100
Creditors amounts falling due after one year10(197,672)-
Provisions for liabilities11(3,535)-
Net assets(5,610)100
Capital and reserves
Called up share capital100100
Profit and loss account(5,710)-
Shareholders' funds(5,610)100
The financial statements were approved and authorised for issue by the Board of Directors on 16 October 2023, and are signed on its behalf by:
SINGH, Sarvjit
Director
Registered Company No. 13655344
THORPE HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Land and buildings25
Plant and machinery25
Fixtures and fittings25
Vehicles25
Office Equipment25
Intangible assets policy
Goodwill is being amortised evenly over its estimated useful life of ten years.
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
4.Employee information

20232022
Average number of employees during the year55
5.Intangible assets

Goodwill

Total

££
Cost or valuation
Additions338,173338,173
At 31 March 23338,173338,173
Amortisation and impairment
Charge for year25,36325,363
At 31 March 2325,36325,363
Net book value
At 31 March 23312,810312,810
At 31 March 22--
6.Property, plant and equipment

Land & buildings

Plant & machinery

Vehicles

Office Equipment

Total

£££££
Cost or valuation
Additions4,00955512,35018,46035,374
At 31 March 234,00955512,35018,46035,374
Depreciation and impairment
Charge for year637702,3162,1355,158
At 31 March 23637702,3162,1355,158
Net book value
At 31 March 233,37248510,03416,32530,216
At 31 March 22-----
7.Stocks

2023

2022

££
Other stocks33,564-
Total33,564-
8.Debtors

2023

2022

££
Trade debtors / trade receivables59,779-
Other debtors9,923100
Prepayments and accrued income2,625-
Total72,327100
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
9.Creditors within one year

2023

2022

££
Trade creditors / trade payables63,440-
Bank borrowings and overdrafts50,454-
Other creditors152,696-
Accrued liabilities and deferred income3,501-
Total270,091-
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
10.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts197,672-
Total197,672-
11.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)3,535-
Total3,535-